Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABBR2 | O75899 | 1/20 | 0.53 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | SRC | P12931 | 1/20 | 0.44 |
| ▸ | CPA1 | P15085 | 2/20 | 0.44 |
| ▸ | CPB1 | P15086 | 1/20 | 0.44 |
| ▸ | CPA3 | P15088 | 1/20 | 0.44 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrogen Sulfide SCHEMBL28282419 | 0.98 | GABBR2 (0.52) | GABBR2GABBR1CYP2C19CYP2D6SRC | |
| Ethylene Glycol SCHEMBL1170971 | 0.94 | GABBR2 (0.48) | GABBR2GABBR1CYP2C19CYP2D6SRC | |
| SCHEMBL999962 | 0.91 | GABBR2 (0.42) | GABBR2GABBR1CYP2C19CYP2D6LMNA | |
| SCHEMBL1303811 | 0.89 | GABBR2 (0.44) | GABBR2GABBR1CYP2C19CYP2D6CPA1 | |
| SCHEMBL1171446 | 0.89 | GABBR2 (0.44) | GABBR2GABBR1CYP2C19CYP2D6CPA1 | |
| Glycerin SCHEMBL3192940 | 0.89 | GABBR2 (0.44) | GABBR2GABBR1CYP2C19CPA1CPB1 | |
| Glycerin SCHEMBL3210246 | 0.89 | GABBR2 (0.44) | GABBR2GABBR1CYP2C19CPA1CPB1 | |
| SCHEMBL1171222 | 0.89 | GABBR2 (0.44) | GABBR2GABBR1CYP2C19CYP2D6CPA1 | |
| Propylene Glycol SCHEMBL1171246 | 0.87 | GABBR2 (0.43) | GABBR2GABBR1CYP2C19MAPTFFAR1 | |
| SCHEMBL999007 | 0.87 | GABBR2 (0.46) | GABBR2GABBR1CYP2C19CYP2D6SRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114835826-A | Zwitterionic cellulose and preparation method and application thereof | 深圳华源再生医学有限公司 | 2022-08-02 | — | — | CN | claimed |
| EP-3854786-B1 | METHOD FOR PRODUCING AMINO ACID DERIVATIVES | UBE CORP (JP) | 2026-02-18 | — | — | EP | disclosed |
| US-12492293-B2 | Multi-component systems for preparing foamed products | ARKEMA FRANCE (FR) | 2025-12-09 | — | — | US | disclosed |
| EP-3868740-B1 | CARBOXYLIC ACID-TYPE LIPID, AND LIPID PARTICLE AND LIPID MEMBRANE CONTAINING CARBOXYLIC ACID-TYPE LIPID | TORAY INDUSTRIES (JP) | 2025-08-06 | — | — | EP | disclosed |
| US-12378450-B2 | Adhesive for endoscope and cured product thereof, and endoscope and method for producing the same | FUJIFILM CORPORATION (JP) | 2025-08-05 | — | — | US | disclosed |
| US-20250205384-A1 | HEMOSTATIC MATERIAL | TORAY INDUSTRIES, INC. (JP) | 2025-06-26 | — | — | US | disclosed |
| US-12325677-B2 | Carboxylic acid-type lipid, and lipid particle and lipid membrane each comprising carboxylic acid-type lipid | TORAY INDUSTRIES, INC. (JP) | 2025-06-10 | — | — | US | disclosed |
| US-20250154361-A1 | RECESS FILLING MATERIAL KIT, CURED PRODUCT THEREOF, AND RECESS FILLING METHOD | RESONAC CORPORATION (JP) | 2025-05-15 | — | — | US | disclosed |
| US-12281074-B2 | Method for producing amino acid derivatives | UBE CORPORATION (JP) | 2025-04-22 | — | — | US | disclosed |
| CN-119707784-A | Process for preparing amino acid derivatives | 株式会社API | 2025-03-28 | — | — | CN | disclosed |
| US-20100029876-A1 | POLYMERIZATION ACCELERATOR, CURABLE COMPOSITION, CURED PRODUCT, AND PROCESS FOR PRODUCING THIOL COMPOUND | SHOWA DENKO K.K. (JP) | 2010-02-04 | — | — | US | disclosed |
| EP-2088163-A1 | CURABLE COMPOSITION CONTAINING HYDROXYL GROUP-CONTAINING THIOL COMPOUND AND CURED PRODUCT THEREOF | Showa Denko K.K. (JP) | 2009-08-12 | — | — | EP | disclosed |
| EP-2030989-A1 | POLYMERIZATION ACCELERATOR, CURABLE COMPOSITION, CURED PRODUCT AND METHOD FOR PRODUCING THIOL COMPOUND | Showa Denko K.K. (JP) | 2009-03-04 | — | — | EP | disclosed |
| US-20090023831-A1 | Curable Composition Containing Thiol Compound | SHOWA DENKO K.K. (JP) | 2009-01-22 | — | — | US | disclosed |
| EP-1983017-A1 | CURABLE COMPOSITION CONTAINING THIOL COMPOUND | Showa Denko K.K. (JP) | 2008-10-22 | — | — | EP | disclosed |
| JP-2003125795-A | METHOD FOR PRODUCING OPTICALLY ACTIVE 2-ACYLTHIO-3- PHENYLPROPIONIC ACIDS OR OPTICALLY ACTIVE 2-MERCAPTO-3- PHENYLPROPIONIC ACIDS | MITSUBISHI GAS CHEM CO INC | 2003-05-07 | — | — | JP | disclosed |
| EP-0528957-A4 | FIVE-MEMBERED RING ALKANOIC ACID LEUKOTRIENE ANTAGONISTS | — | 1993-05-05 | — | — | EP | disclosed |
| EP-0528957-A1 | FIVE-MEMBERED RING ALKANOIC ACID LEUKOTRIENE ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1993-03-03 | — | — | EP | disclosed |
| WO-1991016889-A1 | FIVE-MEMBERED RING ALKANOIC ACID LEUKOTRIENE ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1991-11-14 | — | — | WO | disclosed |
| US-4520196-A | α-Mercaptophenylacetic acid derivatives of imidazole-containing compounds and analogues thereof | AMERICAN HOME PRODUCTS CORPORATION (US) | 1985-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250205384-A1 | HEMOSTATIC MATERIAL | F2, F12, FGB | GABBR2 2457/4885GABBR1 3100/4885CYP2C19 3942/4885 |
| US-20100029876-A1 | POLYMERIZATION ACCELERATOR, CURABLE COMPOSITION, CURED PRODUCT, AND PROCESS FOR PRODUCING THIOL COMPOUND | TMT1A, CCNT1, MGMT | GABBR2 4091/4885GABBR1 4296/4885CYP2C19 3376/4885 |
| US-12325677-B2 | Carboxylic acid-type lipid, and lipid particle and lipid membrane each comprising carboxylic acid-type lipid | PLTP, F2, GP6 | GABBR2 3234/4885GABBR1 3865/4885CYP2C19 2091/4885 |
| US-12281074-B2 | Method for producing amino acid derivatives | PTGS2, PTGES, PTGES2 | GABBR2 2458/4885GABBR1 3000/4885CYP2C19 361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.